|
[1]
|
曾泳添, 陈日玲, 农雪艳, 等. 数字疗法在自闭症筛查到干预的临床研究进展与挑战[J]. 中国全科医学, 2025, 28(14): 1702-170.
|
|
[2]
|
de la Torre-Ubieta, L., Won, H., Stein, J.L. and Geschwind, D.H. (2016) Advancing the Understanding of Autism Disease Mechanisms through Genetics. Nature Medicine, 22, 345-361. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Wang, F., Gao, Y., Liu, Z., Cheng, Z., Liu, S., Zhang, Y., et al. (2025) Boosting 2-Arachidonoylglycerol, but Not N-Acylethanolamine, Ameliorates Autism Symptoms in VPA-Exposed Rats by Modulating Abnormal Neuroinflammation. Neuropharmacology, 276, Article 110501. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Pangrazzi, L., Cerilli, E., Balasco, L., Dall’O’, G.M., Chelini, G., Pastore, A., et al. (2024) N-Acetylcysteine Counteracts Immune Dysfunction and Autism-Related Behaviors in the Shank3b Mouse Model of Autism Spectrum Disorder. Antioxidants, 13, Article 1390. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Loomis, S., Silva, D.G., Savopoulos, R., Cilia, J., Li, J., Davis, M.D., et al. (2025) Behavioral and Transcriptomic Effects of a Novel Cannabinoid on a Rat Valproic Acid Model of Autism. Neuropharmacology, 273, Article 110450. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Takyi, E., Nirmalkar, K., Adams, J. and Krajmalnik-Brown, R. (2025) Interventions Targeting the Gut Microbiota and Their Possible Effect on Gastrointestinal and Neurobehavioral Symptoms in Autism Spectrum Disorder. Gut Microbes, 17, Article 2499580. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Ostrolenk, A., Boisvert, M. and Mottron, L. (2025) What Do Autistic Children Who Are Interested in Letters and Numbers Do with Them? A Qualitative Study. International Journal of Qualitative Studies on Health and Well-Being, 20, Article 2500851. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Shareef, A.A., Kheder, A.H., Albarzinji, N., Karim, K.J., Smail, S.W., Mahmood, A.A., et al. (2025) Oxidative Markers and SOD Variant: Predictors of Autism Severity and Susceptibility. Future Science OA, 11, Article 2483628. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
谢雅静, 时晓敏, 颜世敢, 等. 肠道菌群与精神类疾病相关性研究进展[J]. 中国药理学通报, 2022, 38(11): 1617-1622.
|
|
[10]
|
Simões de Oliveira, L., O’Leary, H.E., Nawaz, S., Loureiro, R., Davenport, E.C., Baxter, P., et al. (2024) Enhanced Hippocampal LTP but Normal NMDA Receptor and AMPA Receptor Function in a Rat Model of CDKL5 Deficiency Disorder. Molecular Autism, 15, Article No. 28. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Kurahashi, H., Kunisawa, K., Tanaka, K.F., Kubota, H., Hasegawa, M., Miyachi, M., et al. (2025) Autism Spectrum Disorder-Like Behaviors Induced by Hyper-Glutamatergic NMDA Receptor Signaling through Hypo-Serotonergic 5-HT1A Receptor Signaling in the Prefrontal Cortex in Mice Exposed to Prenatal Valproic Acid. Neuropsychopharmacology, 50, 739-750. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Xia, Q., Walker, A.K., Song, C., Wang, J., Singh, A., Mobley, J.A., et al. (2023) Effects of Heterozygous Deletion of Autism-Related Gene Cullin-3 in Mice. PLOS ONE, 18, e0283299. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Tumdam, R., Hussein, Y., Garin-Shkolnik, T. and Stern, S. (2024) NMDA Receptors in Neurodevelopmental Disorders: Pathophysiology and Disease Models. International Journal of Molecular Sciences, 25, Article 12366. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Williams, P.G., Sears, L., Watson, W.H., Gunaratnam, B., Feygin, Y., Wright, S.P., et al. (2025) Glutathione, Vitamin C, and Cysteine Use in Autistic Children with Disruptive Behavior: A Double-Blind, Placebo-Controlled Crossover Pilot Study. Journal of Developmental & Behavioral Pediatrics, 46, e17-e24. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Shamabadi, A., Karimi, H., Arabzadeh Bahri, R., Motavaselian, M. and Akhondzadeh, S. (2024) Emerging Drugs for the Treatment of Irritability Associated with Autism Spectrum Disorder. Expert Opinion on Emerging Drugs, 29, 45-56. [Google Scholar] [CrossRef] [PubMed]
|